From TokenPost · · 30s
Greenwich LifeSciences Shares Jump After Trial Poster News
Greenwich LifeSciences shares surged over 25% following Phase 3 cancer trial poster announcements.
In brief
Greenwich LifeSciences shares surged over 25% following Phase 3 cancer trial poster announcements. Greenwich LifeSciences shares rose more than 25% after disclosing two FLAMINGO-01 Phase 3 cancer trial posters for an upcoming medical event. Originally reported by TokenPost.
Greenwich LifeSciences Shares

Greenwich LifeSciences, Inc. shares rose more than 25% Tuesday, Nov. 17.
Trial Poster Announcement
The company disclosed two FLAMINGO-01 Phase 3 cancer trial posters for an upcoming medical event.
Stock Trading Details
The company trades on Nasdaq as GLSI.
The essence
Greenwich LifeSciences shares rose more than 25% after disclosing two FLAMINGO-01 Phase 3 cancer trial posters for an upcoming medical event.
Read the TL;DR — this story on one card.





